PFM Health Sciences, LP 13D and 13G filings for Axsome Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:06 pm Sale |
2022-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
PFM Health Sciences, LP | 1,391,831 3.200% |
-767,902 (-35.56%) |
Filing |
| 2022-10-24 4:01 pm Purchase |
2022-10-14 | 13G | Axsome Therapeutics, Inc. AXSM |
PFM Health Sciences, LP | 2,159,733 5.400% |
2,159,733 (New Position) |
Filing |